DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20182982

Histopathological spectrum of ovarian tumors: an institutional perspective

Angela Phukan, Meghna Borgogoi, Shaolima Ghosh

Abstract


Background: Globally ovarian tumor is one of the leading causes of cancer death among women. Ovarian tumor has varied histiogenesis, clinical behavior and malignant potential. The aims and objectives of the present study is to study the histopathological pattern and age distribution of the ovarian tumors.

Methods: A total of 84 cases were studied from January 2016 to December 2016. They were reviewed and analyzed for age, histopathological findings and clinical presentations. Classification was done according to WHO histologic classification of ovarian tumors.

Results: Of the 84 cases, 75% were benign, 3.6% cases were borderline and 21.4% cases were malignant. Among the histological subtypes surface epithelial tumors comprised of 66.7% followed by germ cell tumors (23.9%). Serous cystadenoma (36.9%) was the most common benign tumor followed by mature cystic teratoma (17.9%). Serous cyst adenocarcinoma (10.7%) was the most common malignant tumour. Tumors were seen over age range of 10-78 years and maximum number of cases were in the 4th to 6th decade. Younger age group primarily presented with benign tumors whereas malignant tumors were common in elderly age group.

Conclusions: Surface epithelial tumors were the commonest ovarian tumor. Maximum numbers of ovarian tumors were in the age range 40-59years and malignant tumors were common in >40 years of age.


Keywords


Histopathology, Mature cystic teratoma, Ovarian tumors, Serous cystadenoma

Full Text:

PDF

References


Young RH. The ovary. In: Sternberg S. diagnostic Surgical Pathology. 17th Ed. New York: Raven Press; 1994:2195.

Novak. Gynacologic and obstetric pathology with clinical and endocrine relation. 8th ed. W.B.: Saunders company;1979.

Hirschowitz L. What is ovarian carcinoma? Southwest Cancer Intelligence Service J. 2000;8:10-5.

McCluggage WG. Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms. J Clin Pathol. 2000 May 1;53(5):327-34.

Edmond DK. Malignant disease of the ovary. In Dewhurst`s Text book of obstetrics and gynecology. 6th edition. 1999:590-600.

Philippe, M. Result of conservative management of epithelial malignant and border line ovarian tumors, Human Reproductive Update J. 2003;9(2):185-92.

Tavassoli FA, Devilee P, editors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC; 2003.

Couto F, Nadkarni NS, Rebello MJ. Ovarian Tumours in Goa-A clinicopathological study. J Obst Gynaecol India. 1993;43(3):408-12.

Maheshwari V, Tyagi SP, Saxena K. Surface epithelial tumors of ovary. Indian J Pathol Microbiol. 1994;37(10):75-85.

Pilli GS, Suneeta KP, Dhaded AV, Yenni VV. Ovarian tumours: a study of 282 cases. J Ind Med Asso. 2002 Jul;100(7):420-3.

Gupta. N, Bisht. D. Retrospective and prospective study of ovarian tumors and tumor like lesions. Indian J Pathol Microbiol. 2007;50(30):525-27.

Prabhakar BR, Maingi K. Ovarian tumoursPrevalence in Punjab. Indian J Pathol Microbiol. 1989;32:276-81.

Tushar K, Asaranti K, Mohapatra PC. Intraoperative cytology of ovarian tumours. J Obstet Gynecol India. 2005;55(4):345-9.

Ramachandra G, Harilal KR, Chinnamma K, Thangavelu H. Ovarian neoplasms-A study of 903 cases. J Obstet Gynecol India. 1972;22:309-15.

Bukhari U, Memon Q, Memon H. Frequency and pattern of ovarian tumours. Pak J Med Sci. 2011;27:884-6.

Momtahen S, Kadivar M, Kazzazi AS, Gholipour F et al: Gynaecologic malignancies in Tehran. Indian J Cancer. 2009;46:226-30.

Misra RK, Sharma SP, Gupta U, Gaur R, Misra SD. Pattern of ovarian neoplasm in eastern U.P. J obstetrics Gynaecol. 1990;41(2):242-6.